Drugs for preventing malaria in travellers

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Jacquerioz, Frederique A ^a   Croft, A M ^b   Bergel, E ^b  

^a TULANE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DAPSONE; DOXYCYCLINE; MEFLOQUINE; PRIMAQUINE; PYRIMETHAMINE; SULFADOXINE;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; INFECTION RISK; MALARIA; MALARIA CONTROL; NAUSEA; PHOTOALLERGY; PLASMODIUM VIVAX; PSYCHOPATHY; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; TRAVEL; VAGINITIS; VOMITING;

EID: 44949260047     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006491     Document Type: Review

References (58)

1. Akhtar 1993 Akhtar S, Mukherjee S. Chloroquine-induced mania. International Journal of Psychiatry in Medicine 1993;23(4):349-56.
2. Anderson 1995 Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, et al.Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Annals of Internal Medicine 1995;123(10):771-3.
3. Askling 2005 Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K. Malaria risk in travelers. Emerging Infectious Diseases 2005; Vol. 11, issue 3: 436-41.
4. Bacaner 2004 Bacaner N, Stauffer B, Boulware DR,Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004;291(23):2856-64.
5. Bausch 2005 Bausch DG. Malaria and other tropical infections in the intensive care unit. In: Fink MP, Abraham E, Vincent J-L, Kochanek P editor(s). Textbook of critical care. 5th Edition. Philadelphia: WB Saunders, 2005:1367-82.
6. Bucher 1997 Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
7. CDC 2005 Centers for Disease Control and Prevention. Information for health care providers: preventing malaria in the pregnant woman (www.cdc.gov/travel/mal_preg_hc.htm). Travelers' Health 13 October 2005 (accessed 8 December 2006).
8. Corne 2004 Corne P, Klouche K, Basset D, Amigues L, Béraud JJ, Jonquet O. Severe imported malaria in adults: a retrospective study of 32 cases admitted to intensive care units. Pathologie Biologie 2004;52(10):622-6.
9. Croft 2001 Croft AM, Baker D, von Bertele MJ. An evidence-based vector control strategy for military deployments: the British Army experience. Médecine Tropicale 2001;61(1):91-8.
10. Croft 2002a Croft AM, Herxheimer A. Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?. BMC Public Health 2002;2:6.
11. Croft 2002b Croft AM, Whitehouse DP, Cook GC, Beer MD. Safety evaluation of the drugs available to prevent malaria. Expert Opinion on Drug Safety 2002;1(1):19-27.
12. Croft 2005 Croft AM. Malaria: prevention in travellers. Clinical Evidence 2005, (14):954-72.
13. Croft 2006 Croft AMJ, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.: CD000138. DOI: 10.1002/14651858.CD000138.pub2.
14. Diemert 2006 Diemert DJ. Prevention and self-treatment of traveler's diarhhea. Clinical Microbiology Reviews 2006;19(3):583- 94.
15. Eliades 2005 Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Roberts JM, et al.Malaria surveillance - United States, 2003. Morbidity and Mortality Weekly Report 2005;54(2):25-39.
16. Filler 2003 Filler S, Causer LM, Newman RD, Barber AM, Roberts JM, MacArthur J, et al.Malaria surveillance - United States, 2001. Morbidity and Mortality Weekly Report - Surveillance Summaries 2003;52(5):1-14.
17. Freedman 2006 Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al.Spectrum of disease and relation to place of exposure among ill returned travelers. New England Journal of Medicine 2006;354(2):119-30.
18. Freeman 1983 Freeman LD, Hooper DR, Lathen DF, Nelson DP, Harrison WO, Anderson DS. Brief prophylaxis with doxycycline for the prevention of traveler's diarrhea. Gastroenterology 1983;84(2):276-80.
19. Gamble 2005 Gamble C, Hollis S. Uncertainty method improved on best-worst case analysis in a binary meta-analysis. Journal of Clinical Epidemiology 2005;58(6):579-88.
20. Gamble 2006 Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.: CD003755. DOI: 10.1002/14651858.CD003755. pub2.
21. Garner 2006 Garner P, Gulmezoglu AM. Drugs for preventing malaria-related illness in pregnant women and death in the newborn. Cochrane Database of Systematic Reviews 2006, Issue 4.
22. Genton 2001 Genton B, d'Acremont V. Clinical features of malaria in returning travelers andmigrants. In: Schlagenhauf-LawlorP editor(s). Travelers' malaria. Hamilton, Ontario: BC Decker, 2001:371-92.
23. Graves 2006a Graves P, Gelband H. Vaccines for preventing malaria (SPf66). Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD005966. DOI:10.1002/14651858.CD005966.
24. Graves 2006b Graves P, Gelband H. Vaccines for preventing malaria (pre-erythrocytic). Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD006198. DOI:10.1002/14651858.CD006198.
25. Graves 2006c Graves P, Gelband H. Vaccines for preventing malaria (blood-stage). Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD006199. DOI:10.1002/14651858.CD006199.
26. Hasin 2006 Hasin T, Davidovitch N, Cohen R, Dagan T, Romem A, Orr N, et al.Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. New England Journal of Medicine 2006;355(2):148-55.
27. Higgins 2005 Higgins J, Green S, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 1 March 2006).
28. Jelinek 2002 Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, Bisoffi Z, et al.Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clinical Infectious Diseases 2002;34(5):572- 6.
29. Jong 2003 Jong EC, McMullen R, editors. The travel and tropical medicine manual. 3rd Edition. Philadelphia: Saunders, 2003.
30. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
31. Leder 2004 Leder K, Black J, O'Brien D, Greenwood Z, Kain KC, Schwartz E, et al.Malaria in travelers: a review of the GeoSentinel Surveillance Network. Clinical Infectious Diseases 2004;39(8):1104-12.
32. Lengeler 2004 Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD000363. DOI:10.1002/14651858.CD000363.pub2.
33. Loutan 2003 Loutan L. Malaria: still a threat to travellers. International Journal of Antimicrobial Agents 2003;21(2):158-63.
34. Mali 2003 Mali S, Parise ME. Provisional data report on malaria surveillance and use of antimalarial chemoprophylaxis. Centers for Disease Control and Prevention. www.cdc.gov/malaria/pdf/antimalarial_report2003.pdf (accessed February 2006).
35. McCarthy 2005 McCarthy JS. Malaria chemoprophylaxis: in war and peace. Medical Journal of Australia 2005;182(4):148-9.
36. Meremikwu 2005 Meremikwu MM, Omari AA, Garner P. Chemoprophylaxis and intermittent treatment for preventing malaria in children. Cochrane Database of Systematic Reviews 2005, Issue 4.Art. No.: CD003756. DOI:10.1002/14651858.CD003756.pub3.
37. Moore 2004 Moore DA, Grant AD, Armstrong M, Stumpfle R, Behrens RH. Risk factors for malaria in UK travellers. Transactions of the Royal Society of Tropical Medicine and Hygiene 2004;98(1):55-63.
38. Muentener 1999 Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-1995): trends and perspectives. Bulletin of the World Health Organization 1999;77(7):560-6.
39. Nadelman 2001 Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, et al.Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New England Journal of Medicine 2001;345(2):79-84.
40. Newman 2004 Newman RD, Parise ME, Barber AM, Steketee RW. Malaria-related deaths among US travelers, 1963-2001. Annals of Internal Medicine 2004;141(7):547-55.
41. Nosten 1999 Nosten F, van Vugt M. Neuropsychiatric adverse effects of mefloquine: what do we know and what should we do?. CNS Drugs 1999;11(1):1-8.
42. Oniyangi 2006 Oniyangi O, Omari AA. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD003489. DOI:10.1002/14651858.CD003489.pub2.
43. Parzy 1997 Parzy D, Doerig C, Pradines B, Rico A, Fusai T,Doury JC. Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation specific polymerase chain reaction and in vitro susceptibility testing. American Journal of Tropical Medicine and Hygiene 1997;57(6):646-50.
44. Raglio 1994 Raglio A, Parea M, Lorenzi N, Avogadri M, Grigis A, Goglio A. Tenyear experience with imported malaria in Bergamo, Italy. Journal of Travel Medicine 1994;1(3):152-5.
45. Review Manager 4.2 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
46. Sack 1986 Sack RB. Antimicrobial prophylaxis of travelers' diarrhea: a selected summary. Reviews of Infectious Diseases 1986;8 Suppl 2:160-6.
47. Schlagenhauf 2003a Schlagenhauf P, Steffen R, Loutan L. Migrants as a major risk group for imported malaria in European countries. Journal of Travel Medicine 2003;10(2):106-7.
48. Schlagenhauf 2003b Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, et al.Tolerability of malaria chemoprophylaxis in nonimmune travellers to sub-Saharan africa: multicentre, randomised, double blind, four arm study. BMJ 2003;327(7423):1078-81.
49. Schoneberg 2003 Schoneberg I, Krause G, Ammon A, Strobel H, Stark K. Malaria surveillance in Germany 2000/2001 - results and experience with a new reporting system. Gesundheitswesen 2003;65(4):263-9.
50. Sehgal 2000 Sehgal SC, Sugunan AP, Murhekar MV, Sharma S, Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. International Journal of Antimicrobial Agents 2000;13(4):249-55.
51. Shanks 2005 Shanks GD, Edstein MD. Modern malaria chemoprophylaxis. Drugs 2005;65(15):2091-110.
52. Taylor 2005 Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A. Macrofilaricidal activity of Wuchereria bancrofti: a double-blind, randomized placebo-controlled trial. Lancet 2005;365(9477):2116- 21.
53. Twartz 1982 Twartz JC, Shirai A, Selvaraju G, Saunders JP, Huxsoll DL, Groves MG. Doxycycline prophylaxis for human scrub typhus. Journal of Infectious Diseases 1982;146(6):811-8.
54. Uppsala 2001 Uppsala Monitoring Centre. WHO Adverse Reaction Terminology (WHO-ART). Uppsala: Uppsala Monitoring Centre, 2001.
55. van Riemsdijk 2002 van Riemsdijk MM, Ditters JM, Sturkenboom MC,Tulen JH, Ligthelm RJ, Overbosch D, et al.Neuropsychiatric events during prophylactic use of mefloquine before travelling. European Journal of Clinical Pharmacology 2002;58(6):441-5.
56. Wellems 2003 Wellems TE, Miller LH. Two worlds of malaria. New England Journal of Medicine 2003;349(16):1496-98.
57. WHO 2006 Roll Back Malaria, World Health Organization. Malaria in Africa. www.rbm.who.int/cmc_upload/0/000/015/370/RBMInfosheet_3.htm (accessed 28 November 2006).
58. WTO 2006 World Tourism Organization. Historical perspective of world tourism. www.world-tourism.org/facts/wtb.html (accessed January 2006).